UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 1951 - 2000 of 2289

<< Start < Prev 31 32 33 34 35 36 37 38 39 40 Next > End >>

Office Based Flexible Cystoscopy May be Less Painful for Men Allowed to View the Procedure
Tuesday, 12 June 2007
BERKELEY, CA (UroToday.com) - Happy patients are those that can watch their office cystoscopy procedure, allowing patients to watch their office cystoscopy on the monitor will reduce their discomfort during the endoscopic examination.
Login to read more...

Seven Years’ Experience with 5-Aminolevulinic Acid in Detection of Transitional Cell Carcinoma of the Bladder
Friday, 08 June 2007
BERKELEY, CA (UroToday.com) - Bladder cancer is the most expensive tumor, costing more in health care dollars than any other cancer in the US.
Login to read more...

Verathon Inc., Maker of BladderScan®, Launches FloPoint® Elite Uroflow System at AUA, Helps Physicians Diagnose Voiding Abnormalities
Wednesday, 06 June 2007
BOTHELL, WASH (Press Release)
Login to read more...

Verathon Inc. Launches Portable BladderScan® BVI 9400 Bladder Volume Instrument with NeuralHarmonics™ Ultrasound Technology at AUA
Wednesday, 06 June 2007
BOTHELL, WASH (Press Release)
Login to read more...

Ikonisys Awarded Contract by Michigan Institute of Urology for Digital Microscopy System and Bladder Cancer Application
Wednesday, 06 June 2007
NEW HAVEN, CONN (Press Release)
Login to read more...

Pathologic Features of Bladder Tumors after Nephroureterectomy or Segmental Ureterectomy for Upper Urinary Tract Transitional Cell Carcinoma
Wednesday, 06 June 2007
BERKELEY, CA (UroToday.com) - It is well known that patients who develop upper tract urothelial tumors are at risk of developing subsequent bladder tumors as well.
Login to read more...

Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guérin (BCG) in Patients with Non–Muscle-Invasive Bladder Carcinoma
Tuesday, 05 June 2007
BERKELEY, CA (UroToday.com) - After transurethral resection of bladder tumors, adjuvant intravesical therapy is commonly used to affect the natural history and decrease the probability of recurrence and progression.
Login to read more...

Can Restaging Transurethral Resection of T1 Bladder Cancer Select Patients for Immediate Cystectomy?
Friday, 01 June 2007
BERKELEY, CA (UroToday.com) - Few areas in the management of bladder cancer remain as controversial as the management of patients with tumors that invade the lamina propria without involving the muscularis propria (T1 tumors).
Login to read more...

Use of Urinary Biomarkers for Bladder Cancer Surveillance: Patient Perspectives
Thursday, 31 May 2007
BERKELEY, CA (UroToday.com) - Current guidelines for surveillance of bladder cancer patients include cystoscopy every 3 months for 2 years, every 6 months for 2 years and then annually.
Login to read more...

AUA 2007 - Report on Superficial Bladder Cancer
Tuesday, 29 May 2007
Login to read more...

AUA 2007 - Report on Bladder Cancer Metastatic Disease - Staging
Tuesday, 29 May 2007
Login to read more...

AUA 2007 - Report on Bladder Cancer Invasive II - Podium Session
Tuesday, 29 May 2007
Login to read more...

AUA 2007 - Report on Bladder Cancer Invasive (I)
Tuesday, 29 May 2007
Login to read more...

AUA 2007 - Review of Bladder Cancer: Detection and Screening
Tuesday, 29 May 2007
Login to read more...

AUA 2007 - Comparison of Lymphovascular Invasion in TURBT and Radical Cystectomy Specimens From Patients with Urothelial Carcinoma
Friday, 25 May 2007
Login to read more...

Leading Urologists Present Studies at the American Urological Association Supporting Use of the NMP22® BladderChek® Test for Diagnosing and Managing Bladder Cancer
Friday, 25 May 2007
Login to read more...

AUA 2007 - TNM Nodal Status Versus Lymph Node Density for Prediction of Disease-Specific Survival After Radical Cystectomy for Bladder Cancer
Friday, 25 May 2007
Login to read more...

AUA 2007 - Contiguous and Non-Contiguous prostatic Urethral Transitional Cell Carcinoma - Does It Impact the Survival?
Friday, 25 May 2007
Login to read more...

AUA 2007 - Cystectomy in the Elderly: does the Survival Benefit in Younger Patients Translate to the Octocenarians?
Friday, 25 May 2007
Login to read more...

AUA 2007 - Basic Investigation on Novel Molecular Components Contributing to the Pathophysiology of Bladder Cancer
Thursday, 24 May 2007
Login to read more...

AUA 2007 - Multiple Investigations in Basic and Translational Aspects of Bladder Cancer
Thursday, 24 May 2007
Login to read more...

AUA 2007 Plenary Session: Presidential Address; “The Survival of Urology: Was Darwin Right?”
Thursday, 24 May 2007
Login to read more...

AUA 2007 Plenary Session: SIU Lecture “What is New in the Management of Upper Tract Transitional Cell Carcinoma”
Thursday, 24 May 2007
Login to read more...

AUA 2007 - Plenary Session: John K. Lattimer Lecture "The Management of Invasive Bladder Cancer: Lessons Learned"
Thursday, 24 May 2007
Login to read more...

AUA 2007 - Plenary Session: State-of-the-Art "Novel Treatment Approaches to Superficial TCC"
Thursday, 24 May 2007
Login to read more...

AUA 2007 - Plenary Session: State-of-the-Art "Is Screening for Bladder Cancer Ready for Prime Time?"
Thursday, 24 May 2007
Login to read more...

AUA 2007 - Plenary Session: AUA Update Practice Guideline - Superficial Bladder Cancer
Thursday, 24 May 2007
Login to read more...

AUA 2007 - Plenary Session - Lessons Learned from 36 Years of Experience
Wednesday, 23 May 2007
Login to read more...

AUA 2007 - Plenary Session - 2007 AUA Guidelines on Bladder Cancer for Non Muscle Invasive Disease
Tuesday, 22 May 2007
Login to read more...

AUA 2007 - State of the Art Lecture - Is Screening for Bladder Cancer Ready for Prime Time?
Tuesday, 22 May 2007
Login to read more...

Podcast - AUA 2007 - Evaluation and Workup of Hematuria among Primary Care Physicians in Miami-Dade County: An Anonymous Questionnaire-based Survey
Tuesday, 22 May 2007
By Alan M. Nieder, MD, Assistant Professor, General Urology and Urologic Oncology, Miller School of Medicine, University of Miami Slide Presentation Poster
Login to read more...

Podcast - AUA 2007 - Impact Risk Factors on the Performance of a Point-of-Care Bladder Cancer Test
Tuesday, 22 May 2007
By Yair Lotan, MD, NMP22 Investigation Group, UT Southwestern Medical Center, Dallas, TX Slide Presentation Poster
Login to read more...

AUA 2007 - Prostate Stem Cell Antigen as a Marker for Bladder Cancer
Tuesday, 22 May 2007
Login to read more...

AUA 2007 - Transurethral Detection and Resection of Bladder Carcinomas Under White or 5-ALA Induced Fluroescence Light: Results of the First Double-Blind Placebo-Controlled Clinical Trial - Bladder Cancer
Tuesday, 22 May 2007
Login to read more...

AUA 2007 - Differential Expression of RAL GTPASES and Their Effectors in Bladder Cancer
Tuesday, 22 May 2007
Login to read more...

AUA 2007 - Differential Regulation of EPHB4 and EPHB2 Receptor Tyrosine Kinases in Normal Bladder and Bladder Transitional Cell Carcinoma
Tuesday, 22 May 2007
Login to read more...

AUA 2007 - PD-L1 (B7-H1) Expression by Urothelial Carcinoma of the Bladder and BCG-Induced Granulomata: Associations with Localized Stage Progression
Tuesday, 22 May 2007
Login to read more...

AUA 2007 - Impact of Risk Factors on the Performance of a Point-of-Care Bladder Cancer Test - Poster
Monday, 21 May 2007
Login to read more...

AUA 2007 - NMP22 as an Adjunct to Urine Cytology and Cystoscopy in the Follow Up of Superficial TCC of Urinary Bladder - Poster
Monday, 21 May 2007
Login to read more...

AUA 2007 - Surgical Therapy of Urothelial Carcinomas
Sunday, 20 May 2007
Login to read more...

AUA 2007 - Sunday Plenary Session: The Expansion and Contraction of Urologic Practice
Sunday, 20 May 2007
Login to read more...

AUA 2007 - SBUR and SUO Session: How Immunology Research Drives Treatment of Bladder Cancer
Sunday, 20 May 2007
Login to read more...

AUA 2007 - SUO Session: Transitional Cell Carcinoma II; Are We Underutilizing Minimally Invasive Approaches for Upper Tract TCC?
Sunday, 20 May 2007
Login to read more...

AUA 2007 - SBUR and SUO Session: Ral GTPases and Friends: New Conspirators in Bladder Cancer Metastasis and Targets for Therapy
Sunday, 20 May 2007
Login to read more...

AUA 2007 - SUO Session: Transitional Cell Carcinoma I, Optimizing Outcomes at Every Stage of Bladder Cancer: Do We Practice It?
Sunday, 20 May 2007
Login to read more...

AUA 2007 - SUO Session: Transitional Cell Carcinoma – Optimizing Outcomes at Various Stages of Bladder Cancer
Sunday, 20 May 2007
Login to read more...

The Effect of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer: Results of a Randomized, Prospective, Double-Blind, Placebo Controlled, Multicenter Study
Thursday, 17 May 2007
BERKELEY, CA (UroToday.com) - BCG immunotherapy is the current 'gold standard' for treatment of non-muscle invasive bladder cancer.
Login to read more...

Clinical Utility of Fluorescent in situ Hybridization for the Surveillance of Bladder Cancer Patients Treated with Bacillus Calmette-Guérin Therapy
Tuesday, 15 May 2007
BERKELEY, CA (UroToday.com) - Adjuvant intravesical therapy with BCG is commonly used to decrease the probability of recurrence and progression in patients with bladder tumors.
Login to read more...

The Concept of Lymph Node Density—Is it Ready for Clinical Practice
Monday, 14 May 2007
BERKELEY, CA (UroToday.com) - Lymph node density is a surrogate marker of the extent (i.e. 'quality') of lymph node dissection during radical cystectomy and impacts patient outcome.
Login to read more...

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

The forgotten cancer: Bladder cancer and women - A Presentation by Liam J. Hurley, MD, FACS

Veterans' health: Improved detection and surveillance of bladder cancer - A Presentation by Liam J. Hurley, MD, FACS

Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: Review of the evidence and recommendations

- by J. Alfred Witjes, MD

Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin

- by Ofer Nativ, MD - Video

Pancreatic and psoas abscesses as a late complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer: A case report and review of the literature

- by Miguel Alvarez-Mugica, MD

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

A Rare Case of Adenocarcinoma of the Urinary Bladder

- by Saleem M. Wani, MD, et al.

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Biomarkers in bladder cancer

The effect of age and gender on bladder cancer: A critical review of the literature

Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

2010 Genitourinary Cancers Symposium
- View Bladder Cancer Session Highlights from 2010 Genitourinary Cancers Symposium

10th Annual Winter Meeting of the Society of Urologic Oncology
- View Bladder Cancer Session Highlights from the 2009 SUO Winter Meeting
The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts